Neurocognitive disorders: Cluster 1 of the proposed meta-structure for DSM-V and ICD-11: Paper 2 of 7 of the thematic section: ‘A proposal for a meta-structure for DSM-V and ICD-11’
The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Abstract
Background: In an effort to group mental disorders on the basis of aetiology, five clusters have been proposed. In this paper, we consider the validity of the first cluster, neurocognitive disorders, within this proposal. These disorders are categorized as ‘Dementia, Delirium, and Amnestic and Other Cognitive Disorders’ in DSM-IV and ‘Organic, including Symptomatic Mental Disorders’ in ICD-10. Method: We reviewed the literature in relation to 11 validating criteria proposed by a Study Group of the DSM-V Task Force as applied to the cluster of neurocognitive disorders. Results: ‘Neurocognitive’ replaces the previous terms ‘cognitive’ and ‘organic’ used in DSM-IV and ICD-10 respectively as the descriptor for disorders in this cluster. Although cognitive/organic problems are present in other disorders, this cluster distinguishes itself by the demonstrable neural substrate abnormalities and the salience of cognitive symptoms and deficits. Shared biomarkers, co-morbidity and course offer less persuasive evidence for a valid cluster of neurocognitive disorders. The occurrence of these disorders subsequent to normal brain development sets this cluster apart from neurodevelopmental disorders. The aetiology of the disorders is varied, but the neurobiological underpinnings are better understood than for mental disorders in any other cluster. Conclusions: Neurocognitive disorders meet some of the salient criteria proposed by the Study Group of the DSM-V Task Force to suggest a classification cluster. Further developments in the aetiopathogenesis of these disorders will enhance the clinical utility of this cluster.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It was rapidly recognized that the application of such 'validators' was much more meaningful for larger groups or disorder spectra than for individual categorical diagnoses.”
From The DSM-5: Classification and criteria changes (2013) · cites this paper as [28]
Citations
Cites
1 retracted
Neuronal pathology in Parkinson?s disease
Schulz, J. B., & Falkenburger, B. H. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0954-y · Cited by 127
RetractedDiagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120 · cited 1×
“Some data have been presented linking some genetic polymorphisms and vulnerability to stress for the aetiology of depression (Caspi et al. 2003), or childhood maltreatment and adult violence (Caspi et al.”
Background(1975) · Medical Entomology and Zoology · Cited by 7,245
Role of genotype in the cycle of violence in maltreated children
Caspi, A., McClay, J., Moffitt, T. E., Mill, J., Martin, J., Craig, I. W., Taylor, A., & Poulton, R. (2002) · Science · doi:10.1126/science.1072290 · Cited by 4,842 · cited 1×
“2003), or childhood maltreatment and adult violence (Caspi et al. 2002), but this work remains at a very preliminary stage and is inadequate to underpin any attempts at classification.”
BackgroundImaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496 · cited 1×
“…compound B has recently been investigated as a biomarker of Alzheimer’s disease, and although there is good correspondence between the signal on positron emission tomography and the amount of b-amyloid deposition (Klunk et al. 2004), many nondemented individuals also have a positive signal.”
BackgroundThe Neuropsychological Assessment
Ogden, J. A. (2005) · Fractured Minds · doi:10.1093/oso/9780195171358.003.0002 · Cited by 4,364
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689 · cited 5×
“For example, the specific abnormalities and neurocognitive profiles associated with AD, frontotemporal dementia (FTD) and dementia with Lewy bodies (DLB) draw obvious distinctions between the disorders.”
BackgroundInfluentialOxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614 · cited 1×
“However, on examining the intervening pathogenetic mechanisms that produce neuronal injury, dysfunction and loss, processes such as oxidation, mitochondrial injury, protein aggregation and apoptosis seem to be shared across some of the disorders (Halliwell, 2006).”
BackgroundEstablishment of Diagnostic Validity in Psychiatric Illness: Its Application to Schizophrenia
ROBINS, E., & GUZE, S. B. (1970) · American Journal of Psychiatry · doi:10.1176/ajp.126.7.983 · Cited by 2,243 · cited 1×
“Using the 11 criteria developed by a DSM-V Task Force Study Group (Hyman et al., personal communication, 3 December 2007), which were based on the original Robins & Guze (1970) criteria for the validity of a psychiatric diagnosis, we reviewed the literature pertaining to these disorders.”
MethodLanphear, B. P., Hornung, R., Khoury, J., Yolton, K., Baghurst, P., Bellinger, D. C., Canfield, R. L., Dietrich, K. N., Bornschein, R., Greene, T., et al. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7688 · Cited by 2,205 · cited 1×
“Neurocognitive deficits have been associated with pesticide/ fungicide and metal exposure, particularly lead (Schwartz et al. 1993 ; Hebert et al. 2000 ; Bleecker et al. 2005 ; Lanphear et al. 2005).”
BackgroundThe Structure of Common Mental Disorders
Krueger, R. F. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.10.921 · Cited by 1,881 · cited 1×
“Researchers have posited that a high rate of comorbidity between like disorders may indicate a common underlying structure (Krueger, 1999 ; Krueger & Markon, 2006 ; Slade & Watson, 2006).”
Background'Vascular Depression' Hypothesis
Alexopoulos, G. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830220033006 · Cited by 1,843
The neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677 · cited 1×
“…necessary nor sufficient for a diagnosis of schizophrenia ; there is no pathognomonic abnormality that is present in all patients with this disorder ; and there is no concordance between demonstrated neural abnormalities and the identifying clinical features of schizophrenia (Harrison, 1999).”
BackgroundLife and Death of Neurons in the Aging Brain
Morrison, J. H., & Hof, P. R. (1997) · Science · doi:10.1126/science.278.5337.412 · Cited by 1,344
(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338 · cited 2×
“AD is often co-morbid with cerebrovascular disease in elderly individuals, and indeed dementia in the very old is usually due to the additive or interactive effects of multiple aetiologies (Ince, 2001).”
BackgroundGene–environment interactions in psychiatry: joining forces with neuroscience
Caspi, A., & Moffitt, T. E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1925 · Cited by 1,300
The prevalence of dementia: A quantitative integration of the literature
Jorm, A. F., Korten, A. E., & Henderson, A. S. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02906.x · Cited by 1,296 · cited 1×
“The dementias typically have a late age of onset, with an exponential increase in incidence after the age of 65 years (Jorm et al. 1987).”
BackgroundOccurrence and outcome of delirium in medical in-patients: a systematic literature review
Siddiqi, N., House, A. O., & Holmes, J. D. (2006) · Age and Ageing · doi:10.1093/ageing/afl005 · Cited by 1,186 · cited 1×
“A higher risk of delirium has been linked with preexisting dementia and is common in elderly medical in-patients (Burns et al. 2004 ; Siddiqi et al. 2006).”
BackgroundReinterpreting comorbidity: a model-based approach to understanding and classifying psychopathology
Krueger, R. F., & Markon, K. E. (2006) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.2.022305.095213 · Cited by 1,171
American Journal of Psychiatry
Ketzenberger, K. E. (2014) · Encyclopedia of Special Education · doi:10.1002/9781118660584.ese0115 · Cited by 1,110
Mild Cognitive Impairment as a Clinical Entity and Treatment Target
Petersen, R. C., & Morris, J. C. (2005) · Archives of Neurology · doi:10.1001/archneur.62.7.1160 · Cited by 935
Brain reserve and dementia: a systematic review
VALENZUELA, M. J., & SACHDEV, P. (2006) · Psychological Medicine · doi:10.1017/s0033291705006264 · Cited by 932
Self-citationMolecular basis of phenotypic variability in sporadc creudeldt‐jakob disease
Parchi, P., Castellani, R., Capellari, S., Ghetti, B., Young, K., Chen, S. G., Farlow, M., Dickson, D. W., Sima, A. A. F., Trojanowski, J. Q., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410390613 · Cited by 864
The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings
Strakowski, S. M., DelBello, M. P., & Adler, C. M. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001585 · Cited by 818 · cited 1×
“amygdala, anterior striatum and thalamus) (Strakowski et al. 2005).”
Does delirium contribute to poor hospital outcomes?: A three-site epidemiologic study
Inouye, S. K., Rushing, J. T., Foreman, M. D., Palmer, R. M., & Pompei, P. (1998) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1998.00073.x · Cited by 702
Delirium Superimposed on Dementia: A Systematic Review
Fick, D. M., Agostini, J. V., & Inouye, S. K. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50468.x · Cited by 636 · cited 1×
“Delirium commonly occurs in elderly patients with dementia in community and hospital samples, with prevalence estimates ranging from 20% to 90% (Fick et al. 2002 ; Leentjens & van der Mast, 2005).”
BackgroundOrganic Psychiatry: The Psychological Consequences of Cerebral Disorder
Lishman, W. (1978) · Cited by 485
Apolipoprotein E and Alzheimer's disease
Strittmatter, W. J., & Roses, A. D. (1996) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.19.030196.000413 · Cited by 477
Overlap Between Pathology of Alzheimer Disease and Vascular Dementia
Kalaria, R. N., & Ballard, C. (1999) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199912003-00017 · Cited by 470
Quinette, P. (2006) · Brain · doi:10.1093/brain/awl105 · Cited by 445
Kopelman, M. D. (2002) · Brain · doi:10.1093/brain/awf229 · Cited by 439
Young, J., & Inouye, S. K. (2007) · BMJ · doi:10.1136/bmj.39169.706574.ad · Cited by 438
Ropacki, S. A., & Jeste, D. V. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.11.2022 · Cited by 431 · cited 1×
“For instance, psychosis has been reported in a median 41% of patients with AD (Ropacki & Jeste, 2005).”
BackgroundThe structure of common DSM-IV and ICD-10 mental disorders in the Australian general population
SLADE, T., & WATSON, D. (2006) · Psychological Medicine · doi:10.1017/s0033291706008452 · Cited by 419 · cited 1×
“Researchers have posited that a high rate of comorbidity between like disorders may indicate a common underlying structure (Krueger, 1999 ; Krueger & Markon, 2006 ; Slade & Watson, 2006).”
BackgroundThe risk of dementia and death after delirium
Rockwood, K. (1999) · Age and Ageing · doi:10.1093/ageing/28.6.551 · Cited by 409 · cited 1×
“Although delirium is considered transient, the predisposing vulnerability links it with poor hospital outcomes and a higher risk of death in elderly individuals (Inouye et al. 1998 ; Rockwood et al. 1999).”
BackgroundSurvival Following a Diagnosis of Alzheimer Disease
Brookmeyer, R., Corrada, M. M., Curriero, F. C., & Kawas, C. (2002) · Archives of Neurology · doi:10.1001/archneur.59.11.1764 · Cited by 407 · cited 1×
“Prognosis for the neurocognitive disorders is poor, with the average duration of dementia from symptom onset to death being 8–10 years (Brookmeyer et al. 2002).”
BackgroundDegeneration of anterior thalamic nuclei differentiates alcoholics with amnesia
Harding, A. (2000) · Brain · doi:10.1093/brain/123.1.141 · Cited by 395 · cited 1×
“Furthermore, neuronal loss in the anterior principal nucleus of the diencephalon is characteristic of Korsakoff’s syndrome, a syndrome with amnesia and frontal-executive dysfunction (Harding et al. 2000 ; Kopelman, 2002).”
BackgroundBrain reserve and cognitive decline: a non-parametric systematic review
VALENZUELA, M. J., & SACHDEV, P. (2006) · Psychological Medicine · doi:10.1017/s0033291706007744 · Cited by 373
Self-citationComputer-assisted imaging to assess brain structure in healthy and diseased brains
Ashburner, J., Csernansk, J. G., Davatzikos, C., Fox, N. C., Frisoni, G. B., & Thompson, P. M. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00304-1 · Cited by 371
Molecular classification of sporadic Creutzfeldt–Jakob disease
Hill, A. F., Joiner, S., Wadsworth, J. D. F., Sidle, K. C. L., Bell, J. E., Budka, H., Ironside, J. W., & Collinge, J. (2003) · Brain · doi:10.1093/brain/awg125 · Cited by 367
Ischemic Basis for Deep White Matter Hyperintensities in Major Depression: A Neuropathological Study
Thomas, A. J., O'Brien, J. T., Davis, S., Ballard, C., Barber, R., Kalaria, R. N., & Perry, R. H. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.9.785 · Cited by 365 · cited 1×
“For instance, cerebrovascular disease may present primarily as a depressive disorder or a neurocognitive disorder, thereby arguing for shared aetiology (Alexopolous et al. 1997 ; Thomas et al. 2002), although the pathophysiological mechanisms will vary because different neural networks are involved to produce distinct…”
BackgroundPredisposing and Precipitating Factors for Delirium in Hospitalized Older Patients
Inouye, S. K. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017177 · Cited by 353 · cited 1×
“Structural abnormalities are not necessarily present in delirium although such abnormalities may increase the vulnerability to delirium (Inouye, 1999).”
BackgroundCole, M. G. (2004) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200401000-00002 · Cited by 351 · cited 1×
“The best example of this is delirium, in which electrophysiological disturbances may be evident and are generally reversible (Cole, 2004).”
BackgroundBiomarkers and surrogate markers: An FDA perspective
Katz, R. (2004) · NeuroRX · doi:10.1602/neurorx.1.2.189 · Cited by 347 · cited 1×
“In the narrower sense, it is a feature that can be used to measure the progress of the disease or the effects of treatment (Katz, 2004).”
BackgroundElevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease
Otto, M., Wiltfang, J., Tumani, H., Zerr, I., Lantsch, M., Kornhuber, J., Weber, T., Kretzschmar, H. A., & Poser, S. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00215-2 · Cited by 341
Vascular Dementia: Incidence and Risk Factors in the Canadian Study of Health and Aging
Hébert, R., Lindsay, J., Verreault, R., Rockwood, K., Hill, G., & Dubois, M.-F. (2000) · Stroke · doi:10.1161/01.str.31.7.1487 · Cited by 325 · cited 1×
“Neurocognitive deficits have been associated with pesticide/ fungicide and metal exposure, particularly lead (Schwartz et al. 1993 ; Hebert et al. 2000 ; Bleecker et al. 2005 ; Lanphear et al. 2005).”
BackgroundThe course of delirium in older medical inpatients: A prospective study
McCusker, J., Cole, M., Dendukuri, N., Han, L., & Belzile, É. (2003) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2003.20602.x · Cited by 275 · cited 1×
“The exceptions are delirium (McCusker et al. 2003) and some transient amnesic disorders (Quinette et al.”
BackgroundREVIEWThe Gene Defects Responsible for Familial Alzheimer's Disease
Tanzi, R. E., Kovacs, D. M., Kim, T.-W., Moir, R. D., Guenette, S. Y., & Wasco, W. (1996) · Neurobiology of Disease · doi:10.1006/nbdi.1996.0016 · Cited by 265 · cited 2×
“Specific genetic abnormalities have been identified as causative in a few neurocognitive disorders including early-onset AD and Huntington’s disease (HD) (Huntington’s Disease Collaborative Research Group, 1993 ; Strittmater & Roses, 1996 ; Tanzi et al. 1996 ; Ertekin-Taner, 2007).”
BackgroundDementia and mortality in persons with Down’s syndrome
Coppus, A., Evenhuis, H., Verberne, G. ‐., Visser, F., Van Gool, P., Eikelenboom, P., & Van Duijin, C. (2006) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2006.00842.x · Cited by 260 · cited 1×
“Neurodevelopmental disorders do not generally share co-morbidities (criterion 9) with the neurocognitive cluster, with some prominent exceptions such as high rates of AD in Down’s syndrome (Holland et al. 2000; Tyrell et al. 2001 ; Coppus et al. 2006).”
BackgroundHolland, A. J., Hon, J., Huppert, F. A., & Stevens, F. (2000) · Journal of Intellectual Disability Research · doi:10.1046/j.1365-2788.2000.00263.x · Cited by 259 · cited 1×
“Neurodevelopmental disorders do not generally share co-morbidities (criterion 9) with the neurocognitive cluster, with some prominent exceptions such as high rates of AD in Down’s syndrome (Holland et al. 2000; Tyrell et al. 2001 ; Coppus et al. 2006).”
BackgroundWright, R. O., & Baccarelli, A. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.12.2809 · Cited by 257
Andrews, G., Goldberg, D. P., Krueger, R. F., Carpenter, W. T., Hyman, S. E., Sachdev, P., & Pine, D. S. (2009) · Psychological Medicine · doi:10.1017/s0033291709990250 · Cited by 242 · cited 2×
“The latter group justifiably forms a distinct cluster (Andrews et al. 2009b).”
BackgroundSelf-citationGenetics of Alzheimer's Disease: A Centennial Review
Ertekin-Taner, N. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.03.009 · Cited by 234 · cited 2×
“Specific genetic abnormalities have been identified as causative in a few neurocognitive disorders including early-onset AD and Huntington’s disease (HD) (Huntington’s Disease Collaborative Research Group, 1993 ; Strittmater & Roses, 1996 ; Tanzi et al. 1996 ; Ertekin-Taner, 2007).”
BackgroundTraumatic brain injury and Alzheimer's disease: a review
Van Den Heuvel, C., Thornton, E., & Vink, R. (2007) · Progress in Brain Research · doi:10.1016/s0079-6123(06)61021-2 · Cited by 213
Burns, A. S., Gallagley, A., & Byrne, J. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.023366 · Cited by 210
Decreased β-amyloid 1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
Otto, M., Esselmann, H., Schulz-Schaeffer, W., Neumann, M., Schröter, A., Ratzka, P., Cepek, L., Zerr, I., Steinacker, P., Windl, O., et al. (2000) · Neurology · doi:10.1212/wnl.54.5.1099 · Cited by 171 · cited 5×
“Histopathological abnormalities characterize some of the dementias ; for example, b-amyloid plaques and neurofibrillary tangles in AD; the pathological isoform of the prion protein in CJD; Pick bodies in some FTD cases ; and Lewy bodies in DLB (Braak & Braak, 1991 ; Prusiner & DeArmond, 1994; Braak et al. 2004 ; Wiltf…”
BackgroundInfluentialDementia in people with Down's syndrome
Tyrrell, J., Cosgrave, M., McCarron, M., McPherson, J., Calvert, J., Kelly, A., McLaughlin, M., Gill, M., & Lawlor, B. A. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.502 · Cited by 169
Prion Diseases and Neurodegeneration
Prusiner, S. B., & DeArmond, S. J. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.001523 · Cited by 166 · cited 1×
“…some of the dementias ; for example, b-amyloid plaques and neurofibrillary tangles in AD; the pathological isoform of the prion protein in CJD; Pick bodies in some FTD cases ; and Lewy bodies in DLB (Braak & Braak, 1991 ; Prusiner & DeArmond, 1994; Braak et al. 2004 ; Wiltfang et al. 2005).”
BackgroundOrganic Psychiatry The Psychological Consequences of Cerebral Disorder
Durward, W. F. (1979) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.42.8.772-a · Cited by 165
Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease
Hainfellner, J. A., Wanschitz, J., Jellinger, K. A., Liberski, P. P., Gullotta, F., & Budka, H. (1998) · Acta Neuropathologica · doi:10.1007/s004010050870 · Cited by 160 · cited 1×
“VaD is characterized by evidence of brain tissue loss due to infarction or subinfarction hypoxaemia due to large- and/or small-vessel disease (Hainfellner et al. 1998 ; Kalaria & Ballard, 1999 ; Armstrong et al. 2005).”
BackgroundOverlap between neurodegenerative disorders
Armstrong, R. A., Lantos, P. L., & Cairns, N. J. (2005) · Neuropathology · doi:10.1111/j.1440-1789.2005.00605.x · Cited by 146 · cited 1×
“VaD is characterized by evidence of brain tissue loss due to infarction or subinfarction hypoxaemia due to large- and/or small-vessel disease (Hainfellner et al. 1998 ; Kalaria & Ballard, 1999 ; Armstrong et al. 2005).”
BackgroundVascular Disease, Depression, and Dementia
Alexopoulos, G. S. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51373.x · Cited by 145 · cited 1×
“2002), although the pathophysiological mechanisms will vary because different neural networks are involved to produce distinct deficits in different patients (Alexopoulos, 2003).”
BackgroundPankratz, N., Byder, L., Halter, C., Rudolph, A., Shults, C. W., Conneally, P. M., Foroud, T., & Nichols, W. C. (2006) · Movement Disorders · doi:10.1002/mds.20663 · Cited by 123
Wiltfang, J., Lewczuk, P., Riederer, P., Grünblatt, E., Hock, C., Scheltens, P., Hampel, H., Vanderstichele, H., Iqbal, K., Galasko, D., et al. (2005) · The World Journal of Biological Psychiatry · doi:10.1080/15622970510029786 · Cited by 117 · cited 2×
“AD has received the greatest attention, and reduced amyloid-b levels and increased phosphorylated tau protein levels in the cerebrospinal fluid (CSF) may be possible biomarkers (Wiltfang et al. 2005).”
BackgroundHarper, C. (2007) · Human & Experimental Toxicology · doi:10.1177/0960327107070499 · Cited by 112 · cited 1×
“The example par excellence is alcohol abuse (Harper, 2007) but many other substances of misuse have been implicated.”
BackgroundNeuronal pathology in Parkinson?s disease
Schulz, J. B. (2005) · Cell and Tissue Research · doi:10.1007/s00441-005-1081-0 · Cited by 101
PET and SPECT Imaging in Psychiatric Disorders
Zipursky, R. B., Meyer, J. H., & Verhoeff, N. P. L. G. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705200303 · Cited by 98 · cited 1×
“In cases in which structural brain abnormality is not present, functional abnormalities seen on positron or single photon emission tomography or functional magnetic resonance imaging do relate to both the presence and the severity of the disorders (Zipursky et al. 2007).”
BackgroundGenetic vulnerability following traumatic brain injury: the role of apolipoprotein E
Nathoo, N. (2003) · Molecular Pathology · doi:10.1136/mp.56.3.132 · Cited by 97 · cited 1×
“ApoE*4 has also been associated with developing VaD, DLB, Creutzfeldt–Jakob disease (CJD) and cognitive impairment following traumatic brain injury, although the reports for the disorders other than AD have been less consistent (Marin et al. 1998 ; van Everbrock et al. 2001 ; Nathoo et al. 2003 ; Pankratz et al. 2006…”
BackgroundAndrews, G., Pine, D. S., Hobbs, M. J., Anderson, T. M., & Sunderland, M. (2009) · Psychological Medicine · doi:10.1017/s0033291709990274 · Cited by 94 · cited 1×
“The latter group justifiably forms a distinct cluster (Andrews et al. 2009b).”
BackgroundSelf-citationTreatment of vascular dementia—evidence from clinical trials with cholinesterase inhibitors
Erkinjuntti, T., Román, G., & Gauthier, S. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.09.018 · Cited by 82
TRINUCLEOTIDE INSTABILITY: A Repeating Theme in Human Inherited Disorders
Gusella, J. F., & MacDonald, M. E. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.201 · Cited by 78
(1962) · Nature · doi:10.1038/1931136d0 · Cited by 76
Schwartz, B. S., Bolla, K. I., Stewart, W., Ford, D. P., Agnew, J., & Frumkin, H. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116757 · Cited by 67 · cited 1×
“Neurocognitive deficits have been associated with pesticide/ fungicide and metal exposure, particularly lead (Schwartz et al. 1993 ; Hebert et al. 2000 ; Bleecker et al. 2005 ; Lanphear et al. 2005).”
BackgroundDelirium in elderly people: an update
Leentjens, A. F. G., & van der Mast, R. C. (2005) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000165603.36671.97 · Cited by 66
Low, L., Brodaty, H., & Draper, B. (2002) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.697 · Cited by 65 · cited 1×
“non-cognitive symptoms of dementia that occur as a result of the underlying disease process (Meins et al. 1998 ; Low et al. 2002).”
BackgroundMeins, W., Frey, A., & Thiesemann, R. (1998) · International Psychogeriatrics · doi:10.1017/s1041610298005468 · Cited by 62 · cited 2×
“non-cognitive symptoms of dementia that occur as a result of the underlying disease process (Meins et al. 1998 ; Low et al. 2002).”
BackgroundThe relationship between apolipoprotein E, dementia, and vascular illness
Marin, D. B., Breuer, B., Marin, M. L., Silverman, J. M., Schmeidler, J., Greenberg, D. A., Flynn, S. P., Mare, M., Lantz, M., Libow, L. S., et al. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00105-1 · Cited by 55 · cited 1×
“ApoE*4 has also been associated with developing VaD, DLB, Creutzfeldt–Jakob disease (CJD) and cognitive impairment following traumatic brain injury, although the reports for the disorders other than AD have been less consistent (Marin et al. 1998 ; van Everbrock et al. 2001 ; Nathoo et al. 2003 ; Pankratz et al. 2006…”
BackgroundBritish Medical Journal Publishing Group (1911) · BMJ · doi:10.1136/bmj.2.2645.574 · Cited by 54
Striatal specificity of gene expression dysregulation in Huntington's disease
Thomas, E. A. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21046 · Cited by 52 · cited 5×
“For example, the specific abnormalities and neurocognitive profiles associated with AD, frontotemporal dementia (FTD) and dementia with Lewy bodies (DLB) draw obvious distinctions between the disorders.”
BackgroundInfluentialEverbroeck, B. V., Croes, E. A., Pals, P., Dermaut, B., Jansen, G. H., van Duijn, C. M., Cruts, M., Broeckhoven, C. V., Martin, J., & Cras, P. P. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02264-9 · Cited by 52
Differential effects of lead exposure on components of verbal memory
Bleecker, M. L., Ford, D. P., Lindgren, K. N., Hoese, V. M., Walsh, K. S., & Vaughan, C. G. (2005) · Occupational and Environmental Medicine · doi:10.1136/oem.2003.011346 · Cited by 49 · cited 1×
“Neurocognitive deficits have been associated with pesticide/ fungicide and metal exposure, particularly lead (Schwartz et al. 1993 ; Hebert et al. 2000 ; Bleecker et al. 2005 ; Lanphear et al. 2005).”
BackgroundHogan, D. B., & Patterson, C. (2002) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s031716710000216x · Cited by 47
Green, A. J. E. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.t01-2-00427.x · Cited by 45 · cited 1×
“1997, 2000), which has another protein that serves as a laboratory test (Green, 2002).”
BackgroundDo personality traits predict the occurrence of Alzheimer's disease?
Meins, W., & Dammast, J. (2000) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(200002)15:2<120::aid-gps84>3.0.co;2-7 · Cited by 40
Wang, P.-S., Wu, Y., Hung, C., Kwan, S.-Y., Teng, S., & Soong, B. (2008) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0b013e318163a7d5 · Cited by 37 · cited 5×
“Although these are not generally specific to the disorder, some, such as CJD, can be recognized by characteristic sharp wave complexes on EEG (Wang et al. 2008).”
BackgroundInfluentialRiepe, M. W., Adler, G., Ibach, B., Weinkauf, B., Tracik, F., & Gunay, I. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000100875 · Cited by 34 · cited 2×
“Cholinesterase inhibitors, specifically donepezil, rivastigmine and galantamine, have been proven to provide symptomatic relief in AD and DLB and possibly VaD, but there is no convincing evidence to suggest that they slow down the disease process (Hogan & Patterson, 2002 ; Erkinjuntti et al. 2004 ; Riepe et al. 2007).”
BackgroundImaging Biomarkers and their Role in Dementia Clinical Trials
Chertkow, H., & Black, S. (2007) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s031716710000562x · Cited by 29
Is It Time to Retire the Term “Dementia”?
Sachdev, P. (2000) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.12.2.276 · Cited by 26 · cited 2×
“…that the diagnosis of dementia disregarded the fact that the disorder had usually been present for a long period prior to the categorical diagnosis, and that the predementia stage had an impact on functioning and also offered an opportunity for intervention now and in the future (Sachdev, 2000).”
BackgroundSelf-citationCan chronic neuroleptic treatment promote sleep disturbances in elderly schizophrenic patients?
Staedt, J., Dewes, D., Dános, P., & Stoppe, G. (2000) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(200002)15:2<170::aid-gps88>3.0.co;2-h · Cited by 24
Genetics of Late-Onset Alzheimer’s Disease: Progress and Prospect
Li, Y., & Grupe, A. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.12.1747 · Cited by 22
Lyketsos, C. G. (2006) · Journal of Neuropsychiatry · doi:10.1176/jnp.2006.18.4.445 · Cited by 22 · cited 1×
“However, these changes are not solely the product of neurological damage but also reflect complex relationships with pre-morbid factors and current demands (Lishman, 1998 ; Lezak et al. 2004 ; Lyketsos, 2006).”
BackgroundPersonality traits and frontal lobe dementia
Lebert, F., Pasquier, F., & Petit, H. (1995) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.930101209 · Cited by 19 · cited 1×
“High pre-morbid neuroticism may be related to the recognition of dementia (Lebert et al. 1995 ; Meins et al. 1998 ; Meins & Dammast, 2000).”
BackgroundA Critique of ‘Organic’ and its Proposed Alternatives
Sachdev, P. S. (1996) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679609076090 · Cited by 11 · cited 4×
“Valenzuela M, Sachdev P (2006a). Brain reserve and”
BackgroundInfluentialSelf-citationBehavioral toxicology: from historical background to future trends.
Iregren, A. (2006) · PubMed · Cited by 6
Lyketsos, C. G. (2006) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.18.4.445 · Cited by 3
Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1
Parchi, P., Giese, A., Capellari, S., Brown, P., Schulz-Schaeffer, W., Windl, O., Zerr, I., Budka, H., Kopp, N., Piccardo, P., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199908)46:2<224::aid-ana12>3.0.co;2-w · cited 5×
“Histopathological abnormalities characterize some of the dementias ; for example, b-amyloid plaques and neurofibrillary tangles in AD; the pathological isoform of the prion protein in CJD; Pick bodies in some FTD cases ; and Lewy bodies in DLB (Braak & Braak, 1991 ; Prusiner & DeArmond, 1994; Braak et al. 2004 ; Wiltf…”
BackgroundInfluential
Research works printed but not linked: 6
- Lezak, 2004, Neuropsychological Assessment
- 10.1002/1531-8249(199910)46:4<598::aid-ana7>3.0.co;2-f · DOI
- Iregren, 2006, Medicina del Lavoro, 97, 332
- Zakzanis, 1999, Neuropsychological Differential Diagnosis: Studies on Neuropsychology, Development and Cognition
- Katz, 2004, NeuroRx, 1, 89
- Andrews, 2009, Psychological Medicine
Cited by
Kotov, R., Krueger, R. F., Watson, D., Achenbach, T. M., Althoff, R. R., Bagby, R. M., Brown, T. A., Carpenter, W. T., Caspi, A., Clark, L. A., et al. (2017) · Journal of Abnormal Psychology · doi:10.1037/abn0000258 · Cited by 3,335
“…(Andrews, Pine, Hobbs, Anderson, & Sunderland, 2009; Carpenter et al., 2009; Goldberg, Krueger, Andrews, & Hobbs, 2009; Krueger & South, 2009; Sachdev, Andrews, Hobbs, Sunderland, & Anderson, 2009), and more recent reviews have continued to support these conclusions (Beauchaine & McNulty,…”
The DSM-5: Classification and criteria changes
Regier, D. A., Kuhl, E. A., & Kupfer, D. J. (2013) · World Psychiatry · doi:10.1002/wps.20050 · Cited by 1,138
“Using an expanded set of “validity criteria” from those originally proposed by Robins and Guze in 1970 (26), a series of analyses and papers were developed that were published in an international psychiatric journal (27-34).”
BackgroundClassifying neurocognitive disorders: the DSM-5 approach
Sachdev, P. S., Blacker, D., Blazer, D. G., Ganguli, M., Jeste, D. V., Paulsen, J. S., & Petersen, R. C. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.181 · Cited by 1,116
Self-citationManagement of Delirium in Palliative Care: a Review
Grassi, L., Caraceni, A., Mitchell, A. J., Nanni, M. G., Berardi, M. A., Caruso, R., & Riba, M. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0550-8 · Cited by 300
Andrews, G., Goldberg, D. P., Krueger, R. F., Carpenter, W. T., Hyman, S. E., Sachdev, P., & Pine, D. S. (2009) · Psychological Medicine · doi:10.1017/s0033291709990250 · Cited by 242
“Sachdev et al. (2009) determined the features shared by disorders in the Neurocognitive cluster ; Andrews et al. (2009) determined the shared features in the Neurodevelopmental cluster ; Carpenter et al. (2009) determined the shared features in the Psychosis cluster ; Goldberg et al. (2009a)…”
BackgroundSelf-citation
Metadata
- Authors
- Sachdev, P., Andrews, G., Hobbs, M. J., Sunderland, M., & Anderson, T. M.
- Affiliations
- UNSW Sydney (AU)
- Corresponding author
- Sachdev, P.
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2009-10-01
- Volume
- 39
- Issue
- 12
- Pages
- 2001-2012
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W2127436881
- Semantic Scholar
- 1677835bed69ab4cf9e13da34b421694a9b8a29e
- Cited by
- 48
- References
- 98
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 5 · 2023: 1 · 2022: 1 · 2021: 5 · 2020: 1 · 2018: 1 · 2017: 3 · 2015: 2 · 2014: 1 · 2013: 3 · 2012: 2
- FWCI
- 49.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychological Medicine (publishedVersion)
- PubMed (publishedVersion)
- RUNE (Research UNE) (submittedVersion)
- Topics
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
- Keywords
- neurocognitive disorders, mental disorder classification, DSM-V, ICD-11, dementia, delirium, amnestic disorders, cognitive impairment, etiology, biomarkers, comorbidities, clinical course, neurodevelopmental disorders
- MeSH terms
- Aged, Aged, 80 and over, Amnesia, Bipolar Disorder, Cognition Disorders, Delirium, Dementia, Major Depressive Disorder, Humans, Intelligence, Middle Aged, Neuropsychological Tests, Terminology as Topic, Obsessive-Compulsive Disorder, Risk Factors, Schizophrenia, Schizophrenic Psychology, Comorbidity, Disease Progression, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.